Sudafed, Tylenol, NyQuil, Theraflu, Mucinex, and Several Store Brands
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
McIntyre et al. v. Kenvue, Inc. and McNeil Consumer Healthcare
23-cv-2862, D. Minn.
(Sept. 2023)
Mucinex, Tylenol, Benadryl, TheraFlu, NyQuil, and Sudafed cold and flu medicines
Falsely marketing that medicines treat congestion when the active ingredient (phenylephrine) is not an effective decongestant
Pending
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing that medicines are decongestants
Allegations: Falsely marketing the products treat nasal congestion
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing medicines as decongestants
Allegations: Falsely marketing that medicines treat congestion
Allegations: Falsely marketing that medicines treat congestion
Allegations: Falsely marketing medicines as nasal decongestants
Allegations: Falsely marketing that medicines treat congestion
Allegations: Falsely marketing medicines as nasal decongestants
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Falsely marketing that medicines relieve nasal congestion
Allegations: Falsely marketing medicines as decongestants
Allegations: Falsely marketing products as decongestants
Allegations: Falsely marketing medicines as decongestants
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing that medicines treat nasal decongestion
Allegations: Falsely marketing that medicines treat congestion and other sinus issues
Allegations: Falsely advertising that products provide faster relief than other acetaminophen products
Allegations: Misleadingly marketing medicines as “non-drowsy” when an ingredient in them causes drowsiness
Allegations: Marketing products as safe without disclosing that they contain a harmful heavy metal
Allegations: Misleadingly marketing that Tylenol rapid release products work faster than other products when they don’t
June 2020: A federal court judge granted final approval of the settlement agreement. December 2019: A federal judge preliminarily approved the settlement agreement. A final fairness hearing is scheduled for…
April 2015: This action was dismissed When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled.. The reasons for the dismissal have not been…
An FDA panel’s recent findings has led to a flood of lawsuits.
Products marketed to clear up stuffy noses and relieve sinus congestion don’t work, researchers say.
Lawsuits claim infant-specific products aren’t any different than acetaminophen medications for older children.